Final ID:
Kobashigawa Jon, Lavine Kory, Kopecky Benjamin
Once-weekly Tirzepatide versus Dulaglutide for Heart Failure Outcomes in Patients with Type 2 Diabetes, ASCVD, and History of Heart Failure (pre-specified analysis of the SURPASS-CVOT Randomized Clinical Trial)Nicholls Stephen, Dalessio David